Nationwide Implementation of Standardized Structured Reporting
NCT03649126 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2018-08-28
Summary
The first objective is to explore factors that impede or facilitate implementation of SSR in pathology (and other disciplines) among the MDT members receiving SSRs. The second objective is to select, develop and evaluate (process and effect outcomes) implementation tools supporting optimal implementation of SSR in pathology. The third objective is to offer implementation tools to all pathology laboratories in the Netherlands and to share the SSR-kit for successful implementation with other medical disciplines
Conditions
- Standardized Structured Reporting
Interventions
- BEHAVIORAL
-
Implementation tools
Implementation tools developed by experts in order to increase the use of SSR in pathology
Sponsors & Collaborators
-
Dutch Cancer Society
collaborator OTHER -
PALGA foundation
collaborator OTHER -
Radboud University Medical Center
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 68 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-08-21
- Primary Completion
- 2020-06-30
- Completion
- 2020-06-30
Countries
- Netherlands
Study Locations
More Related Trials
-
Tumor Molecular Profiling in Patients With Prostate Cancer
NCT05573789 ·Status: COMPLETED
-
UWCCC Molecular Tumor Board Registry
NCT03023202 ·Status: RECRUITING
-
The Belgian Molecular Profiling Program of Metastatic Cancer for Clinical Decision and Treatment Assignment
NCT03873103 ·Status: UNKNOWN
-
Eligibility Screening for the NIH Intramural Research Program Clinical Protocols
NCT00026754 ·Status: COMPLETED
-
DNA Repair, p53 and Apoptosis Phenotypes in Lung Cancer
NCT00339859 ·Status: COMPLETED
-
Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer
NCT02470819 ·Status: WITHDRAWN ·Phase: NA
-
Trained Immunity in Thyroid Carcinoma and Colon Carcinoma
NCT05280379 ·Status: COMPLETED
-
Study to Extend the Maximum Maintenance Flushing Interval for Ports With Distally Valved Catheters
NCT01586026 ·Status: TERMINATED
-
DNA Repair and Genetic Susceptibility to Lung Cancer
NCT00611598 ·Status: COMPLETED
-
Tumor Phenotypes and Correlation to Clinical Outcomes in Cancer
NCT00283530 ·Status: TERMINATED
-
Family Health Study (Validation of a Family History of Cancer Questionnaire for Risk Factor Surveillance)
NCT00341757 ·Status: COMPLETED
-
Study of the Effect of SNPs in p53 and p53 Response Elements on the Inflammatory Response to DNA Damage
NCT01143519 ·Status: COMPLETED
-
Strategic Targeting for Optimal Prevention of Cancer
NCT03897374 ·Status: RECRUITING
-
National Register of Actionable Mutations
NCT05918666 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Outcomes for Offering Genetic Testing in a Tiered Approach
NCT04902144 ·Status: COMPLETED ·Phase: NA
-
CPCT-02 Biopsy Protocol
NCT01855477 ·Status: COMPLETED ·Phase: NA
-
Swiss Prospective, Multicenter Study Sentinel Lymph Node Procedure in Colon Cancer
NCT00826579 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Prospective Randomized Study Comparing Sentinel Lymph Node (SLN) Evaluation With Standard Pathological Evaluation for the Staging of Colon Carcinoma
NCT01623258 ·Status: COMPLETED
-
Using MC1R Genotype to Impact Melanoma Risk Behavior
NCT03509467 ·Status: COMPLETED ·Phase: NA
-
Cancer Stem Cells in Acute Leukemia
NCT03735797 ·Status: ACTIVE_NOT_RECRUITING
-
Non Invasive Cancer Test (NICT): a Proof of Principle Study.
NCT03019471 ·Status: RECRUITING
-
A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data
NCT06877884 ·Status: RECRUITING
-
Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol
NCT05390827 ·Status: RECRUITING
-
Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer
NCT01148407 ·Status: UNKNOWN
-
Investigating Chemotherapy Treatments, Response and Subsets of HIV-associated Kaposi Sarcoma in Malawi
NCT03160183 ·Status: COMPLETED